Your browser doesn't support javascript.
loading
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine.
Su, Shiwei; Chen, Liqing; Yang, Menglan; Liang, Dan; Ke, Bixia; Liu, Zhongqiu; Ke, Changwen; Liao, Guochao; Liu, Liang; Luo, Xiang.
Afiliação
  • Su S; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine Guangzhou China liao@gzucm.edu.cn luoxiang@gzucm.edu.cn.
  • Chen L; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine Guangzhou China liao@gzucm.edu.cn luoxiang@gzucm.edu.cn.
  • Yang M; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou China lliu@gzucm.edu.cn.
  • Liang D; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine Guangzhou China liao@gzucm.edu.cn luoxiang@gzucm.edu.cn.
  • Ke B; Guangdong Provincial Center for Disease Control and Prevention Guangzhou China.
  • Liu Z; Guangdong Provincial Center for Disease Control and Prevention Guangzhou China.
  • Ke C; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine Guangzhou China liao@gzucm.edu.cn luoxiang@gzucm.edu.cn.
  • Liao G; Guangdong Provincial Center for Disease Control and Prevention Guangzhou China.
  • Liu L; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine Guangzhou China liao@gzucm.edu.cn luoxiang@gzucm.edu.cn.
  • Luo X; Guangdong Hengda Biomedical Technology Co., Ltd. Guangzhou China.
RSC Med Chem ; 14(1): 47-55, 2023 Jan 25.
Article em En | MEDLINE | ID: mdl-36760743
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article